➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
McKesson
Medtronic
AstraZeneca
Express Scripts

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Patent: 8,629,317

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,629,317
Title:Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications thereof
Abstract: The invention relates to a non-human transgenic mammal with an IgH locus modified by replacement of the switching sequence S.mu. with all or part of a transgene comprising the gene C.alpha. of a class A human immunoglobulin, including at least the exon, coding for the CH3 domain and the membrane exon and the applications of the above for the production of humanized class IgA antibodies.
Inventor(s): Cogne; Michel (Isle, FR), Sirac; Christophe (Limoges, FR), Bardel; Micael (Couzeix, FR), Decourt; Catherine (Rilhac-Rancon, FR), Le Morvan; Caroline (Vicq-sur-Breuil, FR)
Assignee: Centre National de la Recherche Scientifique (Paris Cedex, FR) Universite de Limoges (Limoges Cedex, FR)
Application Number:10/577,061
Patent Claims:see list of patent claims

Details for Patent 8,629,317

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Centre National de la Recherche Scientifique (Paris Cedex, FR) Universite de Limoges (Limoges Cedex, FR) 2023-10-24 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Centre National de la Recherche Scientifique (Paris Cedex, FR) Universite de Limoges (Limoges Cedex, FR) 2023-10-24 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Centre National de la Recherche Scientifique (Paris Cedex, FR) Universite de Limoges (Limoges Cedex, FR) 2023-10-24 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Express Scripts
Medtronic
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.